| Application no. and date | 05752861.4 (espacenet) (Federated) (European Patent Register), 20050603 | | Patent/reg. no. and date | DK/EP 1750713, 20121017 | | Publication date | 20070214 | | Priority no. and date | US 576573 P, 20040604 | | EP pub. no. and date |
EP 1750713 20070214 | | Effective date | | | Applicant/owner | Bioniche Life Sciences Inc., 231 Dundas St. East
Belleville, Ontario K8N 1E2, CA | | Applicant ref. no. | 56818 | | Inventor | RIVIERE, Marc, 140 avenue Putney
Saint Lambert, Québec J4P 3B1, CA,
READER, Stéphanie, 1791 d'Argenson
Ste-Julie, Quebec J3E 1E3, CA,
RIVIERE, Phillippe, Château Malfart
F-33910 Saint Martin de Laye, FR | | Representative | HOLMBERG, Martin, P.O Box 17704
S-118 93 Stockholm, SE | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 31/12 (2006.01) , A61P 31/14 (2006.01) | | Title | ANVENDELSE AF IMATINIB TIL BEHANDLING AF LEVERSYGDOMME OG VI-RUSINFEKTIONER | | Int. application no. | CA2005000869 | | Int. publication no. | WO2005117885 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
